Ciprofloxacin; Ciprofloxacin Hydrochloride Patent Expiration
Ciprofloxacin; Ciprofloxacin Hydrochloride was first introduced by Bayer Healthcare Pharmaceuticals Inc
Ciprofloxacin; Ciprofloxacin Hydrochloride Patents
Given below is the list of patents protecting Ciprofloxacin; Ciprofloxacin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cipro Xr |
US7709022 (Pediatric) | Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
Dec 23, 2021
(Expired) | Bayer Hlthcare |
| Cipro Xr |
US8187632 (Pediatric) | Sustained-release preparations of quinolone antibiotics |
Dec 23, 2021
(Expired) | Bayer Hlthcare |
| Cipro Xr | US7709022 | Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
Jun 23, 2021
(Expired) | Bayer Hlthcare |
| Cipro Xr | US8187632 | Sustained-release preparations of quinolone antibiotics |
Jun 23, 2021
(Expired) | Bayer Hlthcare |
Ciprofloxacin; Ciprofloxacin Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Ciprofloxacin; Ciprofloxacin Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Ciprofloxacin; Ciprofloxacin Hydrochloride. The first generic version for Ciprofloxacin; Ciprofloxacin Hydrochloride was by Rising Pharma Holdings Inc and was approved on Mar 22, 2007. And the latest generic version is by Watson Laboratories Inc Florida and was approved on Nov 30, 2010.
Given below is the list of companies who have filed for Ciprofloxacin; Ciprofloxacin Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Ciprofloxacin; Ciprofloxacin Hydrochloride. All of these versions come by the name CIPROFLOXACIN EXTENDED RELEASE. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 212.6MG; EQ 287.5MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Nov 30, 2010 |
| 425.2MG; EQ 574.9MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Nov 30, 2010 |
2. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Ciprofloxacin; Ciprofloxacin Hydrochloride. All of these versions come by the name CIPROFLOXACIN EXTENDED RELEASE. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 425.2MG; EQ 574.9MG BASE
(reference standard) | tablet, extended release | Prescription | ORAL | N/A | Mar 26, 2007 |
| 212.6MG; EQ 287.5MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 31, 2007 |
3. ENDO OPERATIONS
Endo Operations Ltd has filed for 2 different strengths of generic version for Ciprofloxacin; Ciprofloxacin Hydrochloride. All of these versions come by the name CIPROFLOXACIN EXTENDED RELEASE. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 425.2MG; EQ 574.9MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Nov 27, 2007 |
| 212.6MG; EQ 287.5MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Nov 27, 2007 |
4. FOSUN PHARMA
Fosun Pharma Usa Inc has filed for 1 generic for Ciprofloxacin; Ciprofloxacin Hydrochloride. This 212.6mg;eq 287.5mg base version comes by the name CIPROFLOXACIN EXTENDED RELEASE. Given below are the details of the strengths of this generic introduced by Fosun Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 212.6MG; EQ 287.5MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Dec 11, 2007 |
Manufacturing Plant Locations New
Fosun Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fosun Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
5. RISING
Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Ciprofloxacin; Ciprofloxacin Hydrochloride. All of these versions come by the name CIPROFLOXACIN EXTENDED RELEASE. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 212.6MG; EQ 287.5MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Mar 22, 2007 |
| 425.2MG; EQ 574.9MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Mar 22, 2007 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
6. WATSON LABS FLORIDA
Watson Laboratories Inc Florida has filed for 1 generic for Ciprofloxacin; Ciprofloxacin Hydrochloride. This 212.6mg;eq 287.5mg base version comes by the name CIPROFLOXACIN EXTENDED RELEASE. Given below are the details of the strengths of this generic introduced by Watson Labs Florida.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 212.6MG; EQ 287.5MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2010 |